Debbie's Journey: Managing Chronic Pain with Low Dose Naltrexone

JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain

NEWS PROVIDED BY

JanOne Inc. 
28 Jun, 2023

PR NewsWire

LDN therapy a new hope for people suffering from chronic pain?

MedExpress Team
17 August 2023
https://www.medexpress.pl/blogosfera/terapia-ldn-nowa-nadzieja-dla-osob-cierpiacych-na-przewlekly-bol/

The Utilization of Low Dose Naltrexone for Chronic Pain

CNS Drugs
28 July 2023
https://pubmed.ncbi.nlm.nih.gov/37505425/

JanOnes Innovative Approach to Addressing Chronic Pain Filing International Patent Application for Low Dose Naltrexone

Best Stocks
28 June 2023
https://beststocks.com/janones-innovative-approach-to-addressing-chr/

Low Dose Naltrexone's Utility for Non-Cancer Centralized Pain Conditions - A Scoping Review

Pain Med
11 June 2023
https://pubmed.ncbi.nlm.nih.gov/37302106/

Low-Dose Naltrexone (LDN) for Chronic Pain at a Single Institution: A Case Series

J Pain Res
14 June 2023
https://pubmed.ncbi.nlm.nih.gov/37337611/

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis

Biomedicines
As revised 23 March 2023
https://www.mdpi.com/2227-9059/11/4/1087